Our results show that pharmacological inhibition of HuR reduces MPNST growth and metastasis, thus highlighting the relevance of HuR as a potential therapeutic target for MPNSTs. This evidence concerns the gene ELAVL1 and malignant peripheral nerve sheath tumor.